Improving outcomes in mantle cell lymphoma patients treated with R-CHOP using autologous transplant.

被引：0
|
作者：
McQuade, Jennifer
Ahmadi, Tahamtan
Porter, David L.
Frey, Noelle V.
Goldstein, Steven C.
Loren, Alison W.
Svoboda, Jakub
Stadtmauer, Edward Allen
Schuster, Stephen J.
Nasta, Sunita
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18540
引用
收藏
页数：1
相关论文
共 50 条
  • [1] R-CHOP for mantle cell lymphoma
    Klumpp, TR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6802 - 6802
  • [2] Real-World Treatment Outcomes and Toxicities of Outpatient R-CHOP/R-DHAP in Patients with Mantle Cell Lymphoma Eligible for Autologous Stem Cell Transplant
    Yang, Jiayu
    Skrabek, Pamela
    Minuk, Leonard
    Moltzan, Catherine
    Kotb, Rami
    Yang, Lin
    Kansara, Roopesh R.
    BLOOD, 2022, 140 : 11983 - 11984
  • [3] R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma
    Frosch, Zachary
    Luskin, Marlise R.
    Landsburg, Daniel J.
    Schuster, Stephen J.
    Svoboda, Jakub
    Loren, Alison W.
    Porter, David L.
    Stadtmauer, Edward A.
    Nasta, Sunita D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (02): : 92 - 97
  • [4] R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma
    Lim, Seah H.
    Esler, William V.
    Periman, Phillip O.
    Beggs, David
    Zhang, Yana
    Townsend, Mary
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (03) : 482 - 484
  • [5] Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R-CHOP
    Jeon, Young-Woo
    O, Joo-Hyun
    Park, Kyung-Sin
    Min, Gi June
    Park, Sung-Soo
    Yoon, Jae-Ho
    Eom, Ki-Seong
    Min, Chang-Ki
    Cho, Seok-Goo
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (06) : 860 - 871
  • [6] R-CHOP plus thalidomide for previously untreated mantle cell lymphoma
    Drach, J.
    Hopfinger, G.
    Fridrik, M.
    Greil, R.
    Thaler, J.
    Keil, F.
    Lang, A.
    Jaeger, U.
    Raderer, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 214 - 215
  • [7] R-CHOP plus THALIDOMIDE FOR PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA
    Drach, W.
    Hopfinger, G.
    Fridrik, M.
    Greil, R.
    Thaler, J.
    Keil, F.
    Lang, A.
    Jaeger, U.
    Raderer, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 394 - 395
  • [8] Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Sinclair, Natalie
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    LEUKEMIA RESEARCH, 2013, 37 (04) : 386 - 391
  • [9] Zanubrutinib, Lenalidomide Combined with R-CHOP As the Frontline Treatment for Mantle Cell Lymphoma
    Zeng, Zhiyong
    Yang, Apeng
    BLOOD, 2023, 142
  • [10] Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma
    Klener, Pavel
    Fronkova, Eva
    Belada, David
    Forsterova, Kristina
    Pytlik, Robert
    Kalinova, Marketa
    Simkovic, Martin
    Salek, David
    Mocikova, Heidi
    Prochazka, Vit
    Blahovcova, Petra
    Janikova, Andrea
    Markova, Jana
    Obr, Ales
    Berkova, Adela
    Kubinyi, Jozef
    Vaskova, Martina
    Mejstrikova, Ester
    Campr, Vit
    Jaksa, Radek
    Kodet, Roman
    Michalova, Kyra
    Trka, Jan
    Trneny, Marek
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 110 - 115
12345